Literature DB >> 16896761

[Standards and perspectives in diagnosis and therapy of bladder carcinoma].

C Stief1, D Zaak, M Stöckle, U Studer, R Knuechel, C Rödel, R Sauer, H Rubben.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16896761     DOI: 10.1007/s00120-006-1134-3

Source DB:  PubMed          Journal:  Urologe A        ISSN: 0340-2592            Impact factor:   0.639


× No keyword cloud information.
  38 in total

1.  Prognostic markers for bladder cancer: International Consensus Panel on bladder tumor markers.

Authors:  Tomonori Habuchi; Michael Marberger; Michael J Droller; George P Hemstreet; H Barton Grossman; Jack A Schalken; Bernd J Schmitz-Dräger; William M Murphy; Aldo V Bono; Peter Goebell; Robert H Getzenberg; Stefan H Hautmann; Edward Messing; Yves Fradet; Vinata B Lokeshwar
Journal:  Urology       Date:  2005-12       Impact factor: 2.649

2.  Does the option of the ileal neobladder stimulate patient and physician decision toward earlier cystectomy?

Authors:  R E Hautmann; T Paiss
Journal:  J Urol       Date:  1998-06       Impact factor: 7.450

Review 3.  Diagnosis of urothelial carcinoma of the bladder using fluorescence endoscopy.

Authors:  Dirk Zaak; Alexander Karl; Ruth Knüchel; Herbert Stepp; Arndt Hartmann; Oliver Reich; Alexander Bachmann; Michael Siebels; Gralf Popken; Christian Stief
Journal:  BJU Int       Date:  2005-08       Impact factor: 5.588

Review 4.  Urine markers for bladder cancer surveillance: a systematic review.

Authors:  Bas W G van Rhijn; Henk G van der Poel; Theo H van der Kwast
Journal:  Eur Urol       Date:  2005-03-23       Impact factor: 20.096

5.  Long-term benefit of 5-aminolevulinic acid fluorescence assisted transurethral resection of superficial bladder cancer: 5-year results of a prospective randomized study.

Authors:  Dmitry I Daniltchenko; Claus R Riedl; Markus D Sachs; Frank Koenig; Kurosch L Daha; Heinz Pflueger; Stefan A Loening; Dietmar Schnorr
Journal:  J Urol       Date:  2005-12       Impact factor: 7.450

6.  Efficacy of radiochemotherapy with platin derivatives compared to radiotherapy alone in organ-sparing treatment of bladder cancer.

Authors:  R Sauer; S Birkenhake; R Kühn; C Wittekind; K M Schrott; P Martus
Journal:  Int J Radiat Oncol Biol Phys       Date:  1998-01-01       Impact factor: 7.038

7.  Cystectomy with prostate sparing for bladder cancer in 100 patients: 10-year experience.

Authors:  Guy Vallancien; Hazem Abou El Fettouh; Xavier Cathelineau; Herve Baumert; Gaelle Fromont; Bertrand Guillonneau
Journal:  J Urol       Date:  2002-12       Impact factor: 7.450

8.  Organ-sparing treatment of advanced bladder cancer: a 10-year experience.

Authors:  J Dunst; R Sauer; K M Schrott; R Kühn; C Wittekind; A Altendorf-Hofmann
Journal:  Int J Radiat Oncol Biol Phys       Date:  1994-09-30       Impact factor: 7.038

9.  Combined-modality treatment and selective organ preservation in invasive bladder cancer: long-term results.

Authors:  Claus Rödel; Gerhard G Grabenbauer; Reinhard Kühn; Thomas Papadopoulos; Jürgen Dunst; Martin Meyer; Karl M Schrott; Rolf Sauer
Journal:  J Clin Oncol       Date:  2002-07-15       Impact factor: 44.544

10.  Role of 5-aminolevulinic acid in the detection of urothelial premalignant lesions.

Authors:  Dirk Zaak; Edwin Hungerhuber; Peter Schneede; Herbert Stepp; Dominic Frimberger; Stefan Corvin; Nikolaus Schmeller; Martin Kriegmair; Alfons Hofstetter; Ruth Knuechel; Ruth Knöchel
Journal:  Cancer       Date:  2002-09-15       Impact factor: 6.860

View more
  2 in total

1.  [Interdisciplinary networking for clinical and molecular questions in non-muscle invasive urothelial carcinoma of the bladder].

Authors:  S Denzinger; A Hartmann; F Hofstaedter; R Knuechel; P J Wild; D Zaak; C Stief; W F Wieland; R Stoehr; M Burger
Journal:  Urologe A       Date:  2007-09       Impact factor: 0.639

2.  [Intravesical radioimmunotherapy of carcinoma in situ of the urinary bladder after BCG failure].

Authors:  M E Autenrieth; T Horn; F Kurtz; K Nguyen; A Morgenstern; F Bruchertseifer; M Schwaiger; M Blechert; C Seidl; R Senekowitsch-Schmidtke; J E Gschwend; K Scheidhauer
Journal:  Urologe A       Date:  2017-01       Impact factor: 0.639

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.